USPTO serial 79046388
ALBIREO
Reviewed by CopyMark Law Group
Status 402
- Filing date
- Status date
- Registration date
- —
- Examiner
- VERHOSEK, WILLIAM T
- Law office
- TMO LAW OFFICE 114 - EXAMINING ATTORNEY ASSIGNED
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ALBIREO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Albireo AB c/o AstraZeneca AB, Legal Dept.
SE-413 46 GÖTEBORG, SE
Other trademarks owned by Albireo AB c/o AstraZeneca AB, Legal Dept.
SE-431 35 Mölndal, SE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mark I. Peroff
Mark I. Peroff Hiscock & Barclay, LLPSeven Times SquareNew York, NY 10036UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for human use in the prevention and treatment of gynaecological diseases and disorders, cardiovascular including dyslipidemia, atherosclerosis and cholesterol lowering diseases and disorders; central nervous system and neurological diseases and disorders; urological diseases and disorders; gastrointestinal diseases and disorders, hepatico- pancreatico biliary- diseases, musculoskeletal diseases and disorders; migraines, pain, inflammation and inflammatory diseases and disorders; autoimmune diseases, metabolic diseases and disorders; respiratory and infectious diseases and disorders; immunological, bacterial, viral, parasitic and fungal diseases and disorders; psychiatric diseases and disorders; allergies; diabetes; obesity; stroke, erectile and sexual dysfunction; haemolytic diseases and disorders; oncological and malignant diseases and disorders; postoperative adhesions; bone diseases and disorders; ophthalmologic disorders and diseases; dermatological disorders and diseases; ophthalmologic preparations; tooth decay, tooth sensitivity, gingivitis, halitosis and periodontal disease; skin and tissue repair and smoking cessation; Sanitary preparations for medical purposes; Veterinary pharmaceutical preparations for the prevention and treatment of gynaccological diseases and disorders, cardiovascular including dyslipidemia, atherosclerosis and cholesterol lowering diseases and disorders; central nervous system and neurological diseases and disorders; urological diseases and disorders; gastrointestinal diseases and disorders; hepatico- pancreatico- biliary- diseases, musculoskeletal diseases and disorders; pain, inflammation and inflammatory diseases and disorders; autoimmune diseases, metabolic diseases and disorders; respiratory and infectious diseases and disorders; immunological, bacterial, viral, parasitic and fungal diseases and disorders; psychiatric diseases and disorders; allergies; diabetes; obesity; stroke, erectile and sexual dysfunction, haemolytic diseases and disorders; oncological and malignant diseases and disorders; postoperative adhesions; bone diseases and disorders; ophthalmologic disorders and diseases; dermatological disorders and diseases; ophthalmologic preparations; tooth decay, gingivitis, halitosis and periodontal disease; skin and tissue repair; all of the foregoing for treating felines, canines, bovines, porcines, equines, llamas, rabbits, rodents, birds, ferrets, poultry, goats and sheep | SECTION 70 - CANCELLED | — |
| 010 | Surgical, medical and veterinary apparatus and instruments, namely, upper gastrointestinal endoscopes/colonoscopes with stents, injection devices for intragastric/intrarectal injection/infusion, dilation balloons with drug delivery systems, targeted delivery devices to specific parts of the gastrointestinal tract using ingested capsules with remote control release mechanism | SECTION 70 - CANCELLED | — |
| 042 | Scientific consulting services and research and design in the field of the development of pharmaceutical and medical preparations and products | SECTION 70 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Albireo AB c/o AstraZeneca AB, Legal Dept.
- Other trademarks owned by José Luis Cabero
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named ALBIREO
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 2, 2018 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Jun 1, 2018 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Mar 22, 2013 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 30, 2011 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 11, 2011 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 9, 2011 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 9, 2010 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jul 9, 2010 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Dec 4, 2009 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Dec 4, 2009 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 4, 2009 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 17, 2009 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Sep 17, 2009 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Sep 17, 2009 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Sep 16, 2009 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Sep 16, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 11, 2009 | PAPER RECEIVED | — | |
| Aug 6, 2009 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| May 14, 2009 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 14, 2009 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Mar 11, 2009 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 11, 2009 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 11, 2009 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 3, 2009 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Mar 3, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 27, 2009 | PAPER RECEIVED | — | |
| Jan 14, 2009 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 13, 2008 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Aug 27, 2008 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 27, 2008 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 27, 2008 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 20, 2008 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Aug 20, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 20, 2008 | ALIE | ASSIGNED TO LIE | — |
| Aug 14, 2008 | PAPER RECEIVED | — | |
| Apr 10, 2008 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Mar 14, 2008 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 23, 2008 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 22, 2008 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 22, 2008 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 21, 2008 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 20, 2008 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 14, 2007 | NWAP | NEW APPLICATION ENTERED | — |
| Dec 13, 2007 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |